PEStore

Buyout PE

ESPIRA Investments

ESPIRA Investments acquires controlling stakes in established, profitable businesses, from Prague, Czech Republic. It states a focus on healthcare & life sciences, consumer & retail, industrials & manufacturing and education.

Disclosed holdings27
Earliest stated investment
HeadquartersPrague, Czech Republic
Stated cheque sizeEUR 1-3M equity per deal

Stated investment criteria

What ESPIRA Investments says it buys

Read from ESPIRA Investments’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Minimum revenue it states€2m1

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. Nothing here is a commitment by ESPIRA Investments to consider any particular business, and nothing on this page is represented as being for sale.

Portfolio

Disclosed holdings

Companies ESPIRA Investments lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
Andrea Ferancova Bartonova
CVCA
Chris Mruck
Dita Stejskalova
Emilia Mamajova
Gender Diversity
Hadewych Cels
Helen Rodwell
ICON Communication Centres Business Process Outsourcing
Jk Education Group
John Little
Lubor Zalman
Magdalena Soucek
Management Buy Out Or Corporate Spin Off Acquisition
Martin Vohanka
Miroslav Tabernaus
Ownership Evolution Or Capital Restructuring
Premier Clinic Healthcare
Radka Kalvarova
Responsible Investment Esg
Richard Seewald
SLOVCA
Summa Linguae Technologies Technology
Tomas Jerabek
Tomas Lesak
Traction Media
spolecenskaodpovednost.cz

Compiled from ESPIRA Investments’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this ESPIRA Investments?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.